Epiminder Ltd (AU:EPI) — Market Cap & Net Worth

$3.59K USD  · AU$5.07K AUD  · Rank #31359

Market Cap & Net Worth: Epiminder Ltd (EPI)

Epiminder Ltd (AU:EPI) has a market capitalization of $3.59K (AU$5.07K) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31359 globally and #1812 in its home market, demonstrating a -10.83% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epiminder Ltd's stock price AU$0.54 by its total outstanding shares 9476 (9.48K).

Epiminder Ltd Market Cap History: 2025 to 2026

Epiminder Ltd's market capitalization history from 2025 to 2026. Data shows growth from $6.84K to $3.59K (0.00% CAGR).

Epiminder Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Epiminder Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of EPI by Market Capitalization

Companies near Epiminder Ltd in the global market cap rankings as of May 6, 2026.

Key companies related to Epiminder Ltd by market ranking:

  • CR Capital AG (XETRA:CRZK): Ranked #31350 globally with a market cap of $4.02K USD ( €3.44K EUR).
  • Milton Capital PLC (LSE:MII): Ranked #31351 globally with a market cap of $3.95K USD ( GBX32.48 Million GBX).
  • Tipco Asphalt Public Company Limited (F:TPY1): Ranked #31360 globally with a market cap of $3.53K USD ( €3.02K EUR).
  • PTT OIL+RET.BUS.-FOR-BA10 (F:7F8): Ranked #31361 globally with a market cap of $3.40K USD ( €2.91K EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#31350 CR Capital AG XETRA:CRZK $4.02K €0.35
#31351 Milton Capital PLC LSE:MII $3.95K GBX0.25
#31360 Tipco Asphalt Public Company Limited F:TPY1 $3.53K €0.33
#31361 PTT OIL+RET.BUS.-FOR-BA10 F:7F8 $3.40K €0.29

Epiminder Ltd Historical Marketcap From 2025 to 2026

Between 2025 and today, Epiminder Ltd's market cap moved from $6.84K to $ 3.59K, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 AU$3.59K -47.55%
2025 AU$6.84K --

End of Day Market Cap According to Different Sources

On May 5th, 2026 the market cap of Epiminder Ltd was reported to be:

Source Market Cap
Yahoo Finance $3.59K USD
MoneyControl $3.59K USD
MarketWatch $3.59K USD
marketcap.company $3.59K USD
Reuters $3.59K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Epiminder Ltd

AU:EPI Australia
Market Cap
$3.59K
AU$5.07K AUD
Market Cap Rank
#31359 Global
#1812 in Australia
Share Price
AU$0.54
Change (1 day)
-3.60%
52-Week Range
AU$0.48 - AU$1.22
All Time High
AU$1.22
About

Epi-Minder Pty Ltd develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder sub-scalp system, an implanted electroencephalography (EEG) monitoring device, including sub-scalp electrode, implant, coil, wearable processor, and Minder companion application. The company was formerly known as Epilepsy Co P… Read more